These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 18096213
1. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice. Naderi N, Haghparast A, Saber-Tehrani A, Rezaii N, Alizadeh AM, Khani A, Motamedi F. Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213 [Abstract] [Full Text] [Related]
2. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. Naderi N, Aziz Ahari F, Shafaghi B, Najarkolaei AH, Motamedi F. J Neural Transm (Vienna); 2008 Nov; 115(11):1501-11. PubMed ID: 18575801 [Abstract] [Full Text] [Related]
3. Cannabinoids and their interactions with diazepam on modulation of serum corticosterone concentration in male mice. Saber-Tehrani A, Naderi N, Hosseini Najarkolaei A, Haghparast A, Motamedi F. Neurochem Res; 2010 Jan; 35(1):60-6. PubMed ID: 19590959 [Abstract] [Full Text] [Related]
5. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Micale V, Cristino L, Tamburella A, Petrosino S, Leggio GM, Drago F, Di Marzo V. Neuropsychopharmacology; 2009 Feb 30; 34(3):593-606. PubMed ID: 18580871 [Abstract] [Full Text] [Related]
6. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR. Neuropharmacology; 2008 Jan 30; 54(1):129-40. PubMed ID: 17904589 [Abstract] [Full Text] [Related]
7. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD. Fidelman S, Mizrachi Zer-Aviv T, Lange R, Hillard CJ, Akirav I. Eur Neuropsychopharmacol; 2018 May 30; 28(5):630-642. PubMed ID: 29519609 [Abstract] [Full Text] [Related]
10. Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze. Gobira PH, Aguiar DC, Moreira FA. Pharmacol Biochem Behav; 2013 Sep 30; 110():33-9. PubMed ID: 23711591 [Abstract] [Full Text] [Related]
13. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours. Roohbakhsh A, Keshavarz S, Hasanein P, Rezvani ME, Moghaddam AH. Basic Clin Pharmacol Toxicol; 2009 Nov 30; 105(5):333-8. PubMed ID: 19614892 [Abstract] [Full Text] [Related]
14. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats. Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB. J Psychopharmacol; 2019 May 30; 33(5):606-614. PubMed ID: 30789299 [Abstract] [Full Text] [Related]
16. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats. Viana TG, Hott SC, Resstel LB, Aguiar DC, Moreira FA. Psychopharmacology (Berl); 2015 May 30; 232(9):1545-53. PubMed ID: 25388290 [Abstract] [Full Text] [Related]
17. Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test. Zaitone SA, El-Wakeil AF, Abou-El-Ela SH. Behav Pharmacol; 2012 Aug 30; 23(4):417-25. PubMed ID: 22750843 [Abstract] [Full Text] [Related]
18. Endocannabinoids mediate anxiolytic-like effect of acetaminophen via CB1 receptors. Umathe SN, Manna SS, Utturwar KS, Jain NS. Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct 01; 33(7):1191-9. PubMed ID: 19580839 [Abstract] [Full Text] [Related]